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improve RT effectiveness, we investigated an entirely novel radiation treatment schedule in combination. A rat model of MPM was used. The RT regime consisted of 10 pulses of low-dose RT (0.2 Gy) using a 3 minute inter-pulse interval (PERT) to a daily dose of 2 Gy. RT tumor response was assessed by microPET/CT (Positron Emission Tomography/Computed Tomography) imaging. In vitro cell survival data demonstrated PERT was not inferior to standard RT (2 Gy single continuous treatments). In vivo, the surgical procedure and tumor model were established and tumor volume determined by in situ by non-invasive imaging. A significant increase in F18-FDG SUVmax was seen over a five week tumor growth period (p=0.031) (BG corrected p=0.019). Non-treated orthotopic tumors necessitated animal sacrifice at 42 days due to invasive tumor burden. However, both Pulsed RT and Standard RT produced tumor growth delays, the duration of the growth delay was similar after both modalities (p=0.863). Animals were sacrificed at 70 days, but with a lower tumor burden than nonirradiated tumors. This difference in tumor burden sacrifice criteria between non-irradiated and irradiated animals can likely be attributed to daily irradiation and the daily anesthesia that was needed for the irradiation procedure. The hypothesis that discontinuous pulsed RT would be more effective than conventionally-delivered continuous standard radiotherapy to the same total dose, and would also be associated with less normal tissue damage, was not supported by the experimental data. However, Pulsed RT was not inferior to standard RT.
INTRODUCTION AND EXPERIMENTAL CONCEPT
Malignant Pleural Mesothelioma (MPM) survival remains poor despite multidisciplinary treatment involving aggressive surgery, chemotherapy and adjuvant radiotherapy (RT). The large RT treatment volume, and concerns about the proximity of radiosensitive normal structures, restricts the tumoricidal dose of radiotherapy that can be delivered. These concerns limit the effectiveness of adjuvant RT. We propose to deliver the radiotherapy using an entirely novel treatment schedule and combine this with post-RT local-delivery of bone marrow-derived stem cells to facilitate normal tissue proliferation. The concept is to deliver 10 pulses of low-dose RT (0.2 Gy) using a 3 minute inter-pulse interval (PERT) to introduce the RT-induced damage at a level that evades ATM dose-dependent DNA damage detection and repair mechanisms.
This research proposal investigated a novel delivery scheme of pulsed radiotherapy; in which the same total daily dose of radiation (2 Gy) is given as 10 individual 0.2 Gy pulses with a 3-minute inter-pulse interval between each individual 0.2 Gy pulse. The total 2 Gy dose is therefore given using a prolonged discontinuous schedule rather than as one continuous treatment used in conventional delivery. The rationale for giving pulsed treatments is that radiation-induced DNA lesions induced by pulsed radiotherapy occurs at a rate below the detection threshold of cellular repair processes in tumor cells, and thus DNA damage accumulates, causing cell death by apoptosis at the next mitosis. (27 gauge) in the muscle surrounding the parietal pleura via a small left-sided incision in the thorax between the fifth intercostal space. The chest wall muscles were re-approximated with sutures, and the skin was closed with absorbable sutures. After implantation, animals were prophylactically treated with Augmentin in drinking water at 0.35 mg/ml concentration for one day before surgery and three days post-surgery. Although this technique provided tumors in the majority of implanted animals, the tissue repair from the surgical incision and suturing was detected by F18-FDG imaging which negated this technique was a method of monitoring tumor response. After consultation with the veterinarian, the implant technique was modified to eliminate the surgical incision and suturing and use palpation to locate the needle at the fifth intercostal space. This change in procedure produced tumors in 65% of the implanted animals but extended the timeframe of the study, under the guidance of the attending veterinarian. Each change to the surgical procedure was achieved using one animal at a time. Consequently, small iterations in the surgical procedure took months to establish since the growth rate of the tumor was slow, and further iterations could not occur until the previous animal had been allowed sufficient time for the tumor to grow and develop, or not. The veterinarian only allowed individual animals to be implanted until the technique was successfully established, as a complex survival-surgery procedure was required; this limited the rate of progress.
However, following implant, tumors developed with 22±14 days of implant, and animals were scanned with PET/CT weekly once tumors were evident.
Page 5 of 13 The modified surgical procedure was established in the new NIH-Foxn1rnu and tumors were imaged in situ with F18-FDG and reconstructed using imaging software (Fig. 1) . The tumors were evident in the pleural cavity. Once established, the tumors increased in size per week as indicated by the changed in F18-FDG SUVmax reading (Fig. 2) The growth rate of the tumors and SUVmax values showed a degree of variability between individual animals (Fig. 4) . These differences could be normalized by comparing the F18-FDG intensity signal between the tumor-masses and normal tissues within each animal for normalized SUVmax plots (Fig. 5) , and to generate a standard (std) and corrected SUVmax value (BG corrected) over the five week period (Fig. 6) . The increase in tumor values (blue bars) over the five week period when compared to the limited changes in muscle and heart indicates the tumors are growing. Once the tumor model had been established, the radiation procedure of administering a low-dose pulsed treatment regime using the micro-irradiator was developed. Animals are anesthetized during irradiation procedure (10 doses of 0.2 Gy given daily for 5 consecutive days) with 2-3% isoflurane; this procedure was defined and wass well-tolerated.
Rats were imaged and treated in a vertical position (Figs. 7 and 8 ). This positional orientation was found to be more effective and reproducible than the prone position as the lung remained extended. A final SARRP treatment plan was finally developed and used to treat orthotopic lung animals with standard 2 Gy treatments and PERT treatments (Fig. 10) , this plan was specific for each individual animal as each tumor was unique. Figure 11 indicates anatomical F18-FDG PET and CT imaging; the area of FDG uptake is clearly evident in the lung of the MPM tumor model. comparative histological assessment proven difficult.
Non-treated tumors necessitated animal sacrifice at 42 days due to tumor burden. However, both
Pulsed RT and Standard RT produced tumor growth delays, the duration of the growth delay was similar after both modalities (p=0.863). Animals were sacrificed at 70 days, but these animals exhibited a lower tumor burden than non-irradiated tumors. This difference in tumor volume for sacrifice criteria between irradiated and non-irradiated tumors can likely to be attributed to daily irradiation and anesthesia that was needed for the irradiation procedure. Pulsed RT was not inferior to standard RT.
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KEY RESEARCH ACCOMPLISHMENTS
• Measure survival response of MPM cells in vitro
• Demonstrated PERT is not inferior to standard RT in vitro
• Established animal model with a change in rat strain to improve tumor reliability
• Demonstrated RT reduces MPM growth in vivo and growth rate in a consistent manner
• Planned treatments on the SARRP
• Treated orthotopic MPM tumors using pulsed and standard RT.
• Evaluated orthotopic tumor growth and treatment response with F18-FDG.
REPORTABLE OUTCOMES AND CONCLUSIONS
The hypothesis was that discontinuous pulsed RT would be more effective than standardlydelivered continuous radiotherapy to the same total dose, and provide less normal tissue damage.
The rationale being that radiation damage produced by pulsed RT occurs below the threshold to activate DNA repair mechanisms and therefore radiation-induced damage would remain unrepaired post-treatment and produce a post-mitotic cell death. By contrast, radiation-induced damage from continuously delivered standard RT would produce suffice damage to activate DNA repair mechanism and therefore would prove be less effective than PRT.
The presented data do not support this hypothesis.
The tumor imaging and radiation treatment delivery was presented as a component of the research paper at the World Molecular Imaging conference by Dr. Sarah Krueger.
FUTURE EXPERIMENTS
The aim of future experiments, should funding be obtained, is to combined pulsed RT with cytotoxic or targeted chemotherapeutic agents to provide better tumor control.
